Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-30

Clinical Trial Update: Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dobutamine use in sepsis patients with maintained hypoperfusion after initial resuscitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dobutamine (dobutamine)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Sepsis, Hypoperfusion | Phase 2 | Status: UNKNOWN